港股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

罗欣药业

16.960

-0.020-0.12%

成交量：72.00万

成交额：1,220.91万

市值：103.39亿

市盈率：24.06

高：16.980

开：16.940

低：16.940

收：16.980

52周最高：16.980

52周最低：10.000

股本：6.10亿

香港流通股本：1.65亿

量比：- -

换手率：0.44%

股息：- -

股息率：- -

净资产收益率：--

总资产收益率：--

市净率：--

市盈率(LYR):- -

市销率: - -

数据加载中...

总览公司新闻资讯公告

罗欣药业：公司最新一期（2026年2月13日）股东总户数为37,614

罗欣药业：拟受让北京健康19.0526%股权

罗欣药业：截止至2026年1月30日，公司股东总户数为37,496

罗欣药业2025年业绩预告释放了哪些信号？

罗欣药业低价“甩卖”子公司引争议，“止血”背后藏匿多重风险

股市必读：罗欣药业(002793)股东户数3.83万户，较上期减少0.94%

罗欣药业(002793.SZ)发预盈，预计前三季度归母净利润2270万元至2520万元，扭亏为盈

原国泰基金经理姜英管3只产品任期均亏损，转行担任罗欣药业董秘，前任董秘年薪84万

罗欣药业聘任姜英为董事会秘书

天坛生物高管辞职，长春高新拟赴港上市，恒瑞医药1类新药获批临床，罗欣药业拟定增募资8.42亿元

知名药企被罚800万元，澳洋健康或易主，长春高新1类新药申报临床，罗欣药业高管辞职，昭衍新药宣布减持

罗欣药业财务负责人变动：陈娴辞职转岗，武永生接任

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/08058/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"08058","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"08058\",,,,,undefined,":{"symbol":"08058","market":"HK","secType":"STK","nameCN":"罗欣药业","latestPrice":16.96,"timestamp":1496649585126,"preClose":16.98,"halted":4,"volume":720000,"delay":0,"changeRate":-0.001177856301531188,"floatShares":164560000,"shares":609600000,"eps":0.7047657565406352,"marketStatus":"退市","change":-0.02,"latestTime":"06-05 15:59:45","open":16.94,"high":16.98,"low":16.94,"amount":12209120,"amplitude":0.002356,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1772674200000},"marketStatusCode":5,"adr":0,"exchange":"SEHK","adjPreClose":16.98,"openAndCloseTimeList":[[1772587800000,1772596800000],[1772600400000,1772611200000]],"volumeRatio":0,"lotSize":2000,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"08058\",,,,,undefined,":{"symbol":"08058","floatShares":164560000,"roa":"--","roe":"--","lyrEps":0,"shares":609600000,"dividePrice":0,"high":16.98,"amplitude":0.002356,"preClose":16.98,"low":16.94,"week52Low":10,"pbRate":"--","week52High":16.98,"institutionHeld":0,"latestPrice":16.96,"eps":0.7047657565406352,"divideRate":0,"volume":720000,"delay":0,"ttmEps":0,"open":16.94},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/08058\",params:#limit:5,,,undefined,":[{"date":"2017-06-16","symbol":"08058","reason":"有条件要约","type":"delisting","dateTimestamp":1497542400000},{"market":"HK","date":"2017-05-12","symbol":"08058","name":"罗欣药业","time":"","type":"earning","dateTimestamp":1494518400000,"reportTimeType":""}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"08058\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"08058\",market:\"HK\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"08058\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2613793773","title":"罗欣药业：公司最新一期（2026年2月13日）股东总户数为37,614","url":"https://stock-news.laohu8.com/highlight/detail?id=2613793773","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613793773?lang=zh_cn&edition=fundamental","pubTime":"2026-02-24 16:18","pubTimestamp":1771921092,"startTime":"0","endTime":"0","summary":"证券之星消息，罗欣药业(002793)02月24日在投资者关系平台上答复投资者关心的问题。投资者提问：请问截止到2月20日(2月13日收盘)公司的股东人数是多少？谢谢罗欣药业回复：尊敬的投资者，您好！公司最新一期(2026年2月13日)股东总户数为37,614。感谢您的关注！为证券之星据公开信息整理，由AI算法生成(网信算备310104345710301240019号)，不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushiyaowen/20260224/32023439.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["08058","BK0239","BK0132","002793","BK0201","BK0001"],"gpt_icon":0},{"id":"2611315947","title":"罗欣药业：拟受让北京健康19.0526%股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2611315947","media":"格隆汇","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611315947?lang=zh_cn&edition=fundamental","pubTime":"2026-02-13 19:51","pubTimestamp":1770983493,"startTime":"0","endTime":"0","summary":"格隆汇2月13日丨罗欣药业(002793.SZ)公布，公司拟以自有资金或自筹资金6,756.052万元受让成都得怡欣华股权投资合伙企业（有限合伙）（简称“成都得怡”）持有的罗欣健康科技（北京）有限公司（简称“北京健康”“标的公司”）19.0526%股权，对应成都得怡实缴出资金额为6,737万元，交易完成后，公司对北京健康持股比例将由80.9474%升至100%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260213195157a4a0b3d0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260213195157a4a0b3d0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["08058","02389","BK1219"],"gpt_icon":0},{"id":"2608859755","title":"罗欣药业：截止至2026年1月30日，公司股东总户数为37,496","url":"https://stock-news.laohu8.com/highlight/detail?id=2608859755","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608859755?lang=zh_cn&edition=fundamental","pubTime":"2026-02-02 16:33","pubTimestamp":1770021190,"startTime":"0","endTime":"0","summary":"证券之星消息，罗欣药业(002793)02月02日在投资者关系平台上答复投资者关心的问题。投资者提问：请问截止1月30日已收盘公司股东人数是多少？谢谢！罗欣药业回复：尊敬的投资者，您好！截止至2026年1月30日，公司股东总户数为37,496。感谢您的关注！为证券之星据公开信息整理，由AI算法生成(网信算备310104345710301240019号)，不构成投资建议。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushiyaowen/20260202/31992440.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0001","BK0132","08058","002793","BK0239","BK0201"],"gpt_icon":0},{"id":"2607109049","title":"罗欣药业2025年业绩预告释放了哪些信号？","url":"https://stock-news.laohu8.com/highlight/detail?id=2607109049","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607109049?lang=zh_cn&edition=fundamental","pubTime":"2026-01-30 22:07","pubTimestamp":1769782025,"startTime":"0","endTime":"0","summary":"1月30日，罗欣药业发布2025年业绩预告。报告期内，公司预计2025年度归属于母公司所有者的净利润将出现亏损，区间为万元至万元。与上年同期(万元)相比，亏损额预计大幅减少万元至万元，同比减亏幅度达%至%。　　报告同时显示，罗欣药业2025年净利润大幅减亏的原因是其核心创新药产品替戈拉生片快速增长的拉动和产品结构和增长质量持续提升。　　今天我们就借机来分析一下，罗欣药业这家老牌公司，当下及未来有哪些看点？","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushijujiao/20260130/31988133.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0132","002793","BK0201","BK0001","BK0239","08058"],"gpt_icon":0},{"id":"2603969552","title":"罗欣药业低价“甩卖”子公司引争议，“止血”背后藏匿多重风险","url":"https://stock-news.laohu8.com/highlight/detail?id=2603969552","media":"新浪证券","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603969552?lang=zh_cn&edition=fundamental","pubTime":"2026-01-16 17:09","pubTimestamp":1768554540,"startTime":"0","endTime":"0","summary":"近日，罗欣药业（维权）一则转让控股子公司的公告引发市场关注。公司将以6250万元的价格将旗下乐康制药100%股权转让给成立仅两年、注册资本仅20万元的君康生物。而截至2025年9月30日，乐康制药净资产为7323.83万元，交易价明显低于净资产。　　这笔“低价出售”背后，不仅暴露出标的公司持续亏损、资产萎缩的经营困境，也折射出罗欣药业近年来为扭亏频频剥离资产、债务压力渐显的复杂局面。　　乐康制药并非罗欣药业近期出售的唯一资产。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/aigcy/2026-01-16/doc-inhhnzav3923248.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["08058","BK0239","BK0132","BK0001","BK0201","002793"],"gpt_icon":0},{"id":"2603522779","title":"股市必读：罗欣药业(002793)股东户数3.83万户，较上期减少0.94%","url":"https://stock-news.laohu8.com/highlight/detail?id=2603522779","media":"中金财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603522779?lang=zh_cn&edition=fundamental","pubTime":"2026-01-13 08:00","pubTimestamp":1768262439,"startTime":"0","endTime":"0","summary":"来自股本股东变化：截至2026年1月9日，罗欣药业股东户数为3.83万户，较前期减少365户，户均持股升至2.84万股。资金流向1月12日主力资金净流出1174.94万元；游资资金净流入310.47万元；散户资金净流入864.47万元。股东户数变动近日罗欣药业披露，截至2026年1月9日公司股东户数为3.83万户，较12月31日减少365.0户，减幅为0.94%。户均持股数量由上期的2.81万股增加至2.84万股，户均持股市值为14.29万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushiyaowen/20260113/31936006.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0239","002793","BK0132","BK0201","08058","BK0001"],"gpt_icon":0},{"id":"2575291207","title":"罗欣药业(002793.SZ)发预盈，预计前三季度归母净利润2270万元至2520万元，扭亏为盈","url":"https://stock-news.laohu8.com/highlight/detail?id=2575291207","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575291207?lang=zh_cn&edition=fundamental","pubTime":"2025-10-14 19:04","pubTimestamp":1760439853,"startTime":"0","endTime":"0","summary":"智通财经APP讯，罗欣药业(002793.SZ)披露2025年前三季度业绩预告，公司预计归属于上市公司股东的净利润2270万元至2520万元，扭亏为盈;扣除非经常性损益后的净利润470万元至590万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1354932.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"罗欣药业(002793.SZ)发预盈，预计前三季度归母净利润2270万元至2520万元，扭亏为盈","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["08058","002793"],"gpt_icon":0},{"id":"2575230296","title":"原国泰基金经理姜英管3只产品任期均亏损，转行担任罗欣药业董秘，前任董秘年薪84万","url":"https://stock-news.laohu8.com/highlight/detail?id=2575230296","media":"新浪基金","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575230296?lang=zh_cn&edition=fundamental","pubTime":"2025-10-14 18:13","pubTimestamp":1760436780,"startTime":"0","endTime":"0","summary":"炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！　　基金经理“转身”上市公司董秘的案例，又添一例。　　10月13日，罗欣药业（维权）发布公告称，因工作调动原因，公司董事会秘书韩风生辞职。董事会随即审议通过聘任姜英为新任董事会秘书。　　罗欣药业公告显示，前任董秘韩风生2024年度的薪酬为84.57万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/observe/2025-10-14/doc-inftwhph4287641.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0239","08058","BK0001","BK0132","002793","BK0201"],"gpt_icon":0},{"id":"2575409976","title":"罗欣药业聘任姜英为董事会秘书","url":"https://stock-news.laohu8.com/highlight/detail?id=2575409976","media":"滚动播报","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575409976?lang=zh_cn&edition=fundamental","pubTime":"2025-10-13 20:35","pubTimestamp":1760358900,"startTime":"0","endTime":"0","summary":"（来源：北京商报）北京商报讯（记者 丁宁）10月13日晚间，罗欣药业（维权）（002793）发布公告称，为完善公司治理结构，确保公司规范运作，经公司董事长提名，董事会提名委员会审查，董事会同意聘任姜英为公司董事会秘书，任期自董事会审议通过之日起至第五届董事会届满之日止。简历显示，姜英，1987年10月出生，中国国籍，无境外永久居留权，硕士研究生学历。北京大学理学、经济学双学位本科，北京大学管理学硕士及香港大学金融学硕士。曾主要任职于国金证券资产管理分公司、光大保德信基金担任分析师，于国泰基金担任分析师、基金经理助理、基金经理。\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2025-10-13/doc-inftucqf2815231.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0132","002793","08058","BK0239","BK0201","BK0001"],"gpt_icon":0},{"id":"2571694643","title":"天坛生物高管辞职，长春高新拟赴港上市，恒瑞医药1类新药获批临床，罗欣药业拟定增募资8.42亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2571694643","media":"谈医说药","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2571694643?lang=zh_cn&edition=fundamental","pubTime":"2025-09-29 23:48","pubTimestamp":1759160919,"startTime":"0","endTime":"0","summary":"博瑞医药：公司获美国FDA批准开展BGM1812注射液用于超重或肥胖治疗的I期临床。公司于2024年5月13日获得申报受理通知书，并于近日获得国家药监局批准。截至公告日，公司就该药品累计研发投入为843.59万元人民币。该药品为治疗晚期恶性实体肿瘤的基因治疗药物，目前全球共有5个溶瘤病毒药物获得审批上市，国内市场约7个药物处于I/II期临床试验阶段。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250930011418a6a6ba5a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250930011418a6a6ba5a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0359201612.USD","91272","LU2543165471.USD","BK1191","LU0359202008.SGD","LU1023057109.AUD","LU0359201885.HKD","08058","01276"],"gpt_icon":0},{"id":"2566946652","title":"知名药企被罚800万元，澳洋健康或易主，长春高新1类新药申报临床，罗欣药业高管辞职，昭衍新药宣布减持","url":"https://stock-news.laohu8.com/highlight/detail?id=2566946652","media":"谈医说药","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566946652?lang=zh_cn&edition=fundamental","pubTime":"2025-09-08 23:17","pubTimestamp":1757344624,"startTime":"0","endTime":"0","summary":"公司于2024年3月26日获得申报受理通知书，并于近日获得国家药监局批准。此次解除质押的股份质押起始日为2023年9月11日，质押解除日为2025年9月5日，质权人为红塔证券股份有限公司。解除质押后，宁波雅本累计质押股份为8760万股，占其所持股份比例33.99%，占公司总股本比例9.09%。截至公告披露日，陈娴未持有公司股份。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250908231958a716f9c9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250908231958a716f9c9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1576","06127","BK1141","08058"],"gpt_icon":0},{"id":"2565500960","title":"罗欣药业财务负责人变动：陈娴辞职转岗，武永生接任","url":"https://stock-news.laohu8.com/highlight/detail?id=2565500960","media":"财中社","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2565500960?lang=zh_cn&edition=fundamental","pubTime":"2025-09-08 17:35","pubTimestamp":1757324100,"startTime":"0","endTime":"0","summary":"9月8日，罗欣药业（维权）发布公告，陈娴因工作调动申请辞去公司财务负责人职务，辞职自2025年9月5日起生效，辞职后将担任公司创新运营管理办公室副主任。公司于2025年9月8日召开董事会，聘任武永生为新任财务负责人，任期自董事会审议通过之日起至第五届董事会届满之日止。2025年中期，罗欣药业实现收入10.77亿元，归母净利润1770万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2025-09-08/doc-infpusih6086599.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0001","BK0201","002793","BK0132","BK0239","08058"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":12,"code":"91000000","status":"200"}]}}